[PDF][PDF] Renin and prorenin disappearance in humans post-nephrectomy: evidence for binding

M Krop, JH de Bruyn, FH Derkx, AH Danser - Front Biosci, 2008 - article.imrpress.com
[Frontiers in Bioscience 13, 3931-3939, May 1, 2008] 3931 Renin and prorenin disappearance
in humans post-nephrectomy: evidence Page 1 [Frontiers in Bioscience 13, 3931-3939, May …

Renin–angiotensin system genetic polymorphisms: Lack of association with CRP levels in patients with coronary artery disease

E Bahramali, N Firouzabadi… - Journal of the Renin …, 2014 - journals.sagepub.com
Angiotensin (Ang) II is believed to be a potential pro-inflammatory factor. The capability of
Ang II to stimulate C-reactive protein (CRP) production has recently been described. Genetic …

[HTML][HTML] Полиморфизм генов ренин-ангиотензиновой системы у больных артериальной гипертензией и ишемической болезнью сердца, осложненной …

НП Дорофеева, АА Кастанаян, СВ Шлык… - Артериальная …, 2005 - cyberleninka.ru
Целью исследования является поиск связи полиморфизма генов
ангиотензинпревращающего фермента (АПФ), ангиотензиногена (АТГ) и рецепторов …

Threonines at position 174 and 235 of the angiotensinogen polypeptide chain are related to familial history of hypertension in a Spanish-Mediterranean population

E Martinez, A Puras, J Escribano… - British journal of …, 2002 - Taylor & Francis
This study investigates the association between the allelic distribution of two polymorphisms
of the angiotensinogen (AGT) gene (T174M and M235T in the polypeptide chain) and blood …

ACE gene dosage modulates pressure-induced cardiac hypertrophy in mice and men

GJJ Silva, ED Moreira, AC Pereira… - Physiological …, 2006 - journals.physiology.org
The influence of genetic factors on complex phenotypes is context dependent, posing a
challenge to quantify the role of single gene variants on this process. Moreover, redundancy …

[HTML][HTML] The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor …

JJ Brugts, MPM de Maat, E Boersma… - … drugs and therapy, 2009 - Springer
Background Angiotensin-converting enzyme (ACE) inhibitors reduce clinical symptoms and
improve outcome in patients with hypertension, heart failure, and stable coronary artery …

Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype

JHM van Esch, JMG van Gool, RJA de Bruin… - Journal of …, 2008 - journals.lww.com
Background Angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism-
related differences in ACE concentration do not result in differences in angiotensin levels …

ACE genotype and ACE inhibitor response in kidney disease: a perspective

G Mayer - American journal of kidney diseases, 2002 - Elsevier
Angiotensin-converting enzyme (ACE) inhibitors have been shown to reduce blood pressure
and slow the progression of renal diseases. However, a substantial interindividual variability …

Pharmacogenetics and healthcare outcomes in patients with chronic heart failure

KM Kim, MD Murray, W Tu, J Robarge, Y Ding… - European journal of …, 2012 - Springer
Purpose To test for associations between genetic polymorphisms of adrenergic receptors
(AR) and other candidate genes and healthcare utilization in heart failure patients, taking …

[HTML][HTML] Генетические предикторы фибрилляции предсердий

АВ Кускаева, СЮ Никулина, АА Чернова… - Рациональная …, 2016 - cyberleninka.ru
Фибрилляция предсердий (ФП) наиболее частое нарушение ритма сердца. Считается,
что именно первичная форма ФП в большинстве случаев является генетически …